Cerebrovascular Ischemic Events in Patients with Takayasu Arteritis
Stroke 53:1550-1557, Mirouse, A.,et al, 2022
Spectrum of Imaging Appearances of Intracranial Cryptococcal Infection in HIV/AIDS Patients in the Anti-Retroviral Therapy Era
Clin Radiol 71:9-17, Offiah, C.E. & Naseer, A., 2016
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Oral Anticoagulation for Cerebral Ischemic of Arterial Origin
Neurol 57:1993-1999, Torn,M.,et al, 2001
Clinical Features and Diagnosis of Takayasu Arteritis
www.UptoDate.com, July, Hunder, G.G., 2013
Discontinuation of Statin Therapy and Clinical and Outcome After Ischemic Stroke
Stroke 38:2652-2657, Colvicchi,F.,et al, 2007
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006
Prevalence of Fabry Disease in Patients with Cryptogenic Stroke: A Prospective Study
Lancet 366:1794-1796,1754, Rolfs,A.,et al, 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Stroke 37:1715-1719,1637, Hays,A.G.,et al, 2006
Distribution and Outcome of Symptomatic Stenoses and Occlusions in Patients With Acute Cerebral Ischemia
Arch Neurol 63:1287-1291, Weimar,C.,et al, 2006
Prognositc Implications of Right-Sided Insular Damage, Cardiac Autonomic Derangement, and Arrhythmias After Acute Ischemic Stroke
Stroke 36:1710-1715, Colivicchi,F.,et al, 2005
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005
Neurological presentation of intravascular lymphoma: report of two cases and discussion of diagnostic challenges
Eur J Neurol 12:710-714, Lozsadi, D.A.,et al, 2005
Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004
Risk of Stroke in Children
Neurol 61:189-194, Fullerton,H.J.,et al, 2003
Calcium Antagonists for Ischemic Stroke
Stroke 32:570-576, Horn,J. &Limburg,M., 2001
Frequency and Predictors of Stroke Death in 5,888 Participants in the Cardiovascular Health Study
Neurol 56:368-375, Longstreth,W.T.,et al, 2001
Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998
IgG Anticardiolipin Antibody Titer>40 GPL & Risk of Subseq Thrombo-Occlusive Events & Death
Stroke 28:1660-1665, Levine,S.R.,et al, 1997
Lubeluzole Treatment of Acute Ischemic Stroke
Stroke 28:2338-2346, Grotta,J., 1997
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Cerebrovascular Complications of Fabry's Disease
Ann Neurol 40:8-17, Mitsias,P.&Levine,S.R., 1996
Clinical Experience with Excitatory Amino Acid Antagonist Drugs
Stroke 26:503-513, Muir,K.W.&Lees,K.R., 1995
Takayasu's Arteritis
Stroke Syndromes, Eds Bogousslavsky & Caplan, Cambridge Univ Press, Chp 48, p 439-442, Naritomi,H., 1995
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
Clinicopath Conf
Subacute Bacterial Endocarditis with Multiple Cerebral Emboli and Mycotic Aneurysm, Case 10-1993, NE, M 8:717-725,1993., 1993
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Hyponatremia is Associated with Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage
Ann Neurol 27:106-108, Hasan,D.,et al, 1990
Cerebral Ischemic Events in Patients with Mitral Valve Prolapse
Stroke 13:448-450, Sandok,B.A.,et al, 1982
Neurologic Complications of Polycythemia
Ann Int Med 57:909, Silverstein,A.,et al, 1962